Statistics
Publications
2
Citations
62
H-Index
2
Active since
2022
Emma de Vries is an author at AstraZeneca (United Kingdom) specializing in life sciences, molecular biology, and therapeutic target identification.
Publications per year
2022–2023
2
2
A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradation
Alice Fletcher, Dean Clift, Emma de Vries et al. · Nature Communications · 2023 · 43 citations · Full text
1–2 of 2